Elevation Oncology Licenses ADC Technology from Synaffix to Drive Pipeline Expansion
LONZA GROUP AG UNSP/ADR (LZAGY)
NASDAQ:AMEX Investor Relations:
lonza.com/about-lonza/investor-relations.aspx
Company Research
Source: PR Newswire
Licensing agreement gives Elevation Oncology access to Synaffix's ADC technology for one program in combination with SYNstatin E™Elevation Oncology nominates a novel HER3 ADC candidate EO-1022 leveraging its antibody as well as Synaffix's proprietary ADC development technologiesAMSTERDAM, Dec. 12, 2024 /PRNewswire/ -- Synaffix B.V., a Lonza company (SIX: LONN) focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs) with best-in-class therapeutic index, today announces that it has entered into a licensing agreement with Elevation Oncology, Inc., an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs.Synaffix gives Elevation Oncology global access to its clinical stage, site-specific ADC technology platform, including GlycoConnect® antibody conjugation technology, HydraSpace® polar spacer tec
Show less
Read more
Impact Snapshot
Event Time:
LZAGY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LZAGY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LZAGY alerts
High impacting LONZA GROUP AG UNSP/ADR news events
Weekly update
A roundup of the hottest topics
LZAGY
News
- Elevation Oncology Licenses ADC Technology from Synaffix to Drive Pipeline ExpansionPR Newswire
- Lonza Group AG (OTCMKTS: LZAGY) was upgraded by analysts at Redburn Atlantic to a "strong-buy" rating.MarketBeat
- Lonza's Synaffix Collaborates with BigHat Biosciences on the Development of a Machine Learning-Designed ADCPR Newswire
- Lonza's Synaffix Collaborates with BigHat Biosciences on the Development of a Machine Learning-Designed ADCPR Newswire
- Lonza Group AG (OTCMKTS: LZAGY) was upgraded by analysts at The Goldman Sachs Group, Inc. to a "strong-buy" rating.MarketBeat
LZAGY
Analyst Actions
- 10/17/24 - KEPLER CHEUVREUX